Hepatorenal syndrome
MONDO:0001382Hepatorenal syndrome is a form of impaired kidney function that occurs in individuals with advanced chronic liver disease. As many as 40% of individuals with cirrhosis and ascites will develop hepatorenal syndrome. Symptoms may include fatigue, abdominal pain, and a general feeling of ill health (malaise). There are two distinct types of hepatorenal syndrome. Type I progresses quickly (within days), leading to kidney failure. Individuals with type I typically have dramatically reduced urine output, edema, and jaundice, and often suffer from hepatic encephalopathy. Type II progresses more slowly, over weeks or months, and the symptoms are less severe. The cause of hepatorenal syndrome is unknown. A contributing factor seems to be a narrowing of the blood vessels that connect into the kidneys. This causes a decrease in blood flow to the kidneys, impairing their function. In some cases, triggers or precipitating factors (infections, blood loss from the gastrointestinal tract, low blood pressure) are involved. Treatment is aimed at helping the liver work better and maintaining kidney function. In many cases, a liver transplant is needed. In some cases, individuals also need a kidney transplant.
Also known as: hepato-renal syndrome
12 clinical trials for this condition and its sub-types.
Follow this condition to get notified about new trialsBroader categories
-
Could a common supplement help liver patients in intensive care?
Disease control Recruiting nowThis study looks at whether adding L-carnitine, a natural substance, to standard care can improve outcomes for critically ill adults with liver disease in the ICU. About 58 participants with conditions like liver failure or severe infections will be enrolled. Researchers will tra…
Phase 4 • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New algorithm aims to guide fluid treatment for kidney injury in cirrhosis patients
Disease control Recruiting nowThis study tests a volume assessment guidance algorithm (VAGA) to help doctors decide how much and what type of IV fluid to give cirrhosis patients with acute kidney injury. Fifty hospitalized adults with cirrhosis and kidney injury will be randomly assigned to receive either VAG…
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
500 patient records reviewed to understand Kidney-Liver syndrome outcomes
Knowledge-focused Recruiting nowThis study reviews medical records of 500 adults hospitalized with hepatorenal syndrome (HRS), a serious kidney problem linked to liver disease. Researchers aim to understand death rates, complications, and costs associated with HRS. No new treatments are given; the goal is to le…
Sponsor: Methodist Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC